Baxter Healthcare Corporation announced today that the U.S. Food and Drug Administration (FDA) has classified Baxter’s recent Urgent Product Recall regarding Increased Intraperitoneal Volume (IIPV), ...
DEERFIELD, Ill., December 11, 2001 - Baxter Healthcare Corporation announced today it has received clearance from the U.S. Food and Drug Administration (FDA) to market its HomeChoice Pediatric ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) today announced completion of CE marking (market approval) in Europe for HOMECHOICE CLARIA, an automated peritoneal dialysis (APD ...
Baxter International Inc.BAX recently announced that it has received CE marking approval in Europe for HOMECHOICE CLARIA - its automated peritoneal dialysis (APD) system integrated with the ...
The Food & Drug Administration warns Baxter Healthcare Corp. about problems with its HomeChoice peritoneal dialysis systems after reports of patients developing peritonitis. The Food & Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results